Search clinical trials for: Extended Interval Dosing

Total 5298 results

National University Hospital, Singapore

Not yet recruiting

A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers (VALUE-CHECK)

Carcinoma, Hepatocellular | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Oesophageal Cancer | GastroEsophageal Cancer

Singapore
University of Chicago

Recruiting

Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

Metastatic Cancer

United States
Amsterdam UMC, location VUmc
Innovatiefonds Zorgverzekeraars; Stichting MS Research; Stichting Treatmeds

Enrolling by invitation

Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis (SUPERNEXT)

Relapsing Remitting Multiple Sclerosis

Netherlands
University Hospital, Caen
Biogen

Completed

Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort (RELEVANT)

Multiple Sclerosis, Relapsing-Remitting

France
University Health Network, Toronto
Canadian Society of Hospital Pharmacists

Withdrawn

Dosing Intervals of Opioid Medication for Chronic Pain

Chronic Pain

Canada
Ipsen

Completed

Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects (SOMACROL)

Acromegaly

Spain, Portugal
Simon Francis Thomsen
Aarhus University Hospital

Recruiting

Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria (EXOTIC)

Chronic Spontaneous Urticaria | Chronic Urticaria, Idiopathic

Denmark
Murdoch Childrens Research Institute
Sydney Children's Hospitals Network; Royal Children's Hospital; Monash Health; Royal...

Not yet recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2) (VANCAPP)

Infections | Sepsis | Bacteremia

Australia
University of Chicago

Recruiting

A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic

United States
Xinhua Hospital, Shanghai Jiao Tong University...
Beijing YouAn Hospital; Beijing Ditan Hospital; First Affiliated Hospital, Sun... and other collaborators

Recruiting

The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

Non-alcoholic Fatty Liver Disease

China
Gdansk University of Physical Education and Sport
Pomeranian Medical University Szczecin; Medical University of Gdansk; University...

Recruiting

HIIT vs MICT During Pregnancy and Health and Birth Outcomes in Mothers and Children (HIIT MAMA)

Depression | Back Pain | Urinary Incontinence | Pregnancy | Anxiety | Body Composition | Cognitive Function | Pelvic Floor Disorders | Noncommunicable Diseases | Physical Fitness | Metabolism | Postpartum | Health Status | Pregnancy Induced Hypertension | Pain Threshold | Childbirth | Diabetes Mellitus, Gestational | Biomecha...

Poland
Children's Hospital of Philadelphia
Patient-Centered Outcomes Research Institute

Recruiting

Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA)

Juvenile Spondyloarthritis

United States, Canada
Centre for Addiction and Mental Health

Recruiting

"Extended" (Alternate Day) Antipsychotic Dosing

Drug Therapy | Schizophrenia and Related Disorders | Antipsychotic Agents | Drug Administration Schedule

Canada
Boston Children's Hospital
Bristol-Myers Squibb

Recruiting

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis (ABA3)

Graft Vs Host Disease

United States
Berkovich, Regina MD, PhD Inc.
Biogen; Cedars-Sinai Medical Center

Recruiting

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States
Centre Hospitalier de Valenciennes
University Hospital, Lille; Centre Hospitalier de Bethune; Centre Hospitalier... and other collaborators

Recruiting

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study (BLIPIC)

Pneumonia | Continuous Renal Replacement Therapy | Antibiotic | Beta-lactam

France
Vanderbilt University Medical Center
National Center for Complementary and Integrative Health (NCCIH)

Completed

Breathing Interventions for Relaxation: Dosing Through Extended Exhale

Stress | Healthy Adults

United States
Centre for Addiction and Mental Health
National Alliance for Research on Schizophrenia and Depression

Completed

Antipsychotic Medication Extended Dosing Study

Schizophrenia

Canada
Institut de Recherche pour le Developpement
Chiang Mai University; The Government Pharmaceutical Organization

Completed

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment (ALTER)

HIV

Thailand
AMIpharm Co., Ltd.

Completed

Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

Moderate or Severe Submental Fullness

Korea, Republic of
Memorial Sloan Kettering Cancer Center
Schering-Plough

Completed

Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma

Melanoma

United States
University of Cincinnati
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Moderate-Intensity Exercise Versus High-Intensity Interval Training to Recover Walking Post-Stroke

Stroke

United States
Vanda Pharmaceuticals

Completed

Relapse Prevention Study in Patients With Schizophrenia (REPRIEVE)

Schizophrenia

United States, India, Ukraine
Temple University
Veloxis Pharmaceuticals

Completed

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

Kidney Transplant

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Extended Dosing With Eltrombopag for Severe Aplastic Anemia

Severe Aplastic Anemia (SAA)

United States
Baylor Research Institute

Active, not recruiting

Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen (Veloxis)

Compliance, Patient | Graft Failure | Heart Transplant Rejection

United States
New York Institute of Technology

Terminated

Lower Leg Compression in Extended Video Game Play: A Pilot Study

Sedentary Behavior | Compression; Vein | Compression; Artery | DVT of Legs

United States
AstraZeneca

Completed

To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours

Solid Tumours

Denmark, Belgium, United Kingdom, Netherlands
G. d'Annunzio University

Completed

Kinetics of cEVs Over the 24-hour Dosing Interval After Low-dose Aspirin Administration

Cardiovascular Diseases | Vesicle
Radboud University Medical Center
Erasmus Medical Center

Active, not recruiting

Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients (LADI)

Crohn Disease | Crohn Disease in Remission

Netherlands
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; Meilleur Accès aux Soins de Santé (M.A....

Completed

Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

Cholera Vaccination Reaction | Adverse Reaction to Cholera Vaccine

Cameroon
Chulalongkorn University

Completed

Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A

Severe Hemophilia A Without Inhibitor

Thailand
Amsterdam UMC, location VUmc

Completed

The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis (WOC)

Multiple Sclerosis

Netherlands
Mallinckrodt

Completed

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Hepatic Cirrhosis | Hepatic Encephalopathy (HE)

United States, Puerto Rico
Shire

Completed

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

Attention-Deficit/Hyperactivity Disorder

United States, Canada
Ain Shams University

Completed

Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting

Pain, Postoperative | Nausea, Postoperative | Vomiting, Postoperative

Egypt
Johns Hopkins Bloomberg School of Public Health

Completed

Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine

Cholera | Vibrio Cholerae Infection

Zambia
Janssen-Cilag International NV

Completed

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia (PERFlexS)

Schizophrenia

France, United Kingdom, Belgium, Germany, Spain, Portugal, Bulgaria, Serbia, Switzerland, Israel, Finland, Greece, Sweden, Russian Federation, Netherlands, Denmark, Hungary, Lithuania, Latvia, Croatia, Turkey, Poland
Genuine Research Center, Egypt
Multi-Apex Pharma

Completed

Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Industries, Egypt) Versus Myrbetriq 25 mg Extended Release Tablets (Marketed by Astellas Pharma US, Inc, Product of Japan)

Healthy

Egypt
Swiss Federal Institute of Technology

Completed

The Effect of Lactoferrin and Dosing Regimen on Iron Absorption From a Maize-based Porridge in Kenyan Infants

Iron-deficiency

Kenya
Medical University of South Carolina
Astellas Pharma Inc

Completed

Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients

Immunosuppression

United States
William S. Middleton Memorial Veterans Hospital
University of Wisconsin, Madison

Completed

Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service

Anticoagulation
Unity Health Toronto
Mount Sinai Hospital, Canada; Women's College Hospital

Unknown

Extended Pessary Interval for Care (EPIC Study) (EPIC)

Pelvic Organ Prolapse | Pessary

Canada
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Immune Thrombocytopenia

China
Ipsen

Completed

Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects (LEAD)

Acromegaly

France, Brazil, Denmark, Finland, Greece, Korea, Republic of, Latvia, Netherlands, Norway, Poland, Romania, Russian Federation, Serbia, Sweden
University of Illinois at Chicago
Astellas Pharma US, Inc.

Completed

A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients (Tacrolimus ER)

Kidney Transplantation

United States
Hamilton Health Sciences Corporation
The Physicians' Services Incorporated Foundation

Completed

Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients

Venous Thrombosis | Atrial Fibrillation | Heart Valve Diseases

Canada
University Hospital, Ghent

Completed

Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion

Infectious Disease

Belgium
National Cancer Institute (NCI)
Celgene Corporation

Terminated

Lenalidomide Maintenance Therapy for Multiple Myeloma

Multiple Myeloma

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors

Cancer

United States, Australia, United Kingdom

Search clinical trials for: Extended Interval Dosing

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations